##fileformat=VCFv4.1
##fileDate=20150327
##source=freeBayes v0.9.20-16-g3e35e72
##reference=/mnt/share/data/dbs//genomes/hg19.fa
##phasing=none
##commandline="/mnt/share/opt/freebayes20150204/bin/freebayes -b ./NA12878.bam -f /mnt/share/data/dbs//genomes/hg19.fa -t /tmp/vc_freebayes_a7QW9v.bed --min-alternate-fraction 0.15 --min-base-quality 20 --min-alternate-qsum 90"
##filter="QUAL > 5 & AO > 2"
##INFO=<ID=NS,Number=1,Type=Integer,Description="Number of samples with data">
##INFO=<ID=DP,Number=1,Type=Integer,Description="Total read depth at the locus">
##INFO=<ID=DPB,Number=1,Type=Float,Description="Total read depth per bp at the locus; bases in reads overlapping / bases in haplotype">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Total number of alternate alleles in called genotypes">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=AF,Number=A,Type=Float,Description="Estimated allele frequency in the range (0,1]">
##INFO=<ID=RO,Number=1,Type=Integer,Description="Reference allele observation count, with partial observations recorded fractionally">
##INFO=<ID=AO,Number=A,Type=Integer,Description="Alternate allele observations, with partial observations recorded fractionally">
##INFO=<ID=PRO,Number=1,Type=Float,Description="Reference allele observation count, with partial observations recorded fractionally">
##INFO=<ID=PAO,Number=A,Type=Float,Description="Alternate allele observations, with partial observations recorded fractionally">
##INFO=<ID=QR,Number=1,Type=Integer,Description="Reference allele quality sum in phred">
##INFO=<ID=QA,Number=A,Type=Integer,Description="Alternate allele quality sum in phred">
##INFO=<ID=PQR,Number=1,Type=Float,Description="Reference allele quality sum in phred for partial observations">
##INFO=<ID=PQA,Number=A,Type=Float,Description="Alternate allele quality sum in phred for partial observations">
##INFO=<ID=SRF,Number=1,Type=Integer,Description="Number of reference observations on the forward strand">
##INFO=<ID=SRR,Number=1,Type=Integer,Description="Number of reference observations on the reverse strand">
##INFO=<ID=SAF,Number=A,Type=Integer,Description="Number of alternate observations on the forward strand">
##INFO=<ID=SAR,Number=A,Type=Integer,Description="Number of alternate observations on the reverse strand">
##INFO=<ID=SRP,Number=1,Type=Float,Description="Strand balance probability for the reference allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SRF and SRR given E(SRF/SRR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=SAP,Number=A,Type=Float,Description="Strand balance probability for the alternate allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SAF and SAR given E(SAF/SAR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=AB,Number=A,Type=Float,Description="Allele balance at heterozygous sites: a number between 0 and 1 representing the ratio of reads showing the reference allele to all reads, considering only reads from individuals called as heterozygous">
##INFO=<ID=ABP,Number=A,Type=Float,Description="Allele balance probability at heterozygous sites: Phred-scaled upper-bounds estimate of the probability of observing the deviation between ABR and ABA given E(ABR/ABA) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RUN,Number=A,Type=Integer,Description="Run length: the number of consecutive repeats of the alternate allele in the reference genome">
##INFO=<ID=RPP,Number=A,Type=Float,Description="Read Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPPR,Number=1,Type=Float,Description="Read Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPL,Number=A,Type=Float,Description="Reads Placed Left: number of reads supporting the alternate balanced to the left (5') of the alternate allele">
##INFO=<ID=RPR,Number=A,Type=Float,Description="Reads Placed Right: number of reads supporting the alternate balanced to the right (3') of the alternate allele">
##INFO=<ID=EPP,Number=A,Type=Float,Description="End Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=EPPR,Number=1,Type=Float,Description="End Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=DPRA,Number=A,Type=Float,Description="Alternate allele depth ratio.  Ratio between depth in samples with each called alternate allele and those without.">
##INFO=<ID=ODDS,Number=1,Type=Float,Description="The log odds ratio of the best genotype combination to the second-best.">
##INFO=<ID=GTI,Number=1,Type=Integer,Description="Number of genotyping iterations required to reach convergence or bailout.">
##INFO=<ID=TYPE,Number=A,Type=String,Description="The type of allele, either snp, mnp, ins, del, or complex.">
##INFO=<ID=CIGAR,Number=A,Type=String,Description="The extended CIGAR representation of each alternate allele, with the exception that '=' is replaced by 'M' to ease VCF parsing.  Note that INDEL alleles do not have the first matched base (which is provided by default, per the spec) referred to by the CIGAR.">
##INFO=<ID=NUMALT,Number=1,Type=Integer,Description="Number of unique non-reference alleles in called genotypes at this position.">
##INFO=<ID=MEANALT,Number=A,Type=Float,Description="Mean number of unique non-reference allele observations per sample with the corresponding alternate alleles.">
##INFO=<ID=LEN,Number=A,Type=Integer,Description="allele length">
##INFO=<ID=MQM,Number=A,Type=Float,Description="Mean mapping quality of observed alternate alleles">
##INFO=<ID=MQMR,Number=1,Type=Float,Description="Mean mapping quality of observed reference alleles">
##INFO=<ID=PAIRED,Number=A,Type=Float,Description="Proportion of observed alternate alleles which are supported by properly paired read fragments">
##INFO=<ID=PAIREDR,Number=1,Type=Float,Description="Proportion of observed reference alleles which are supported by properly paired read fragments">
##INFO=<ID=technology.ILLUMINA,Number=A,Type=Float,Description="Fraction of observations supporting the alternate observed in reads from ILLUMINA">
##INFO=<ID=ESP6500EA_AF,Number=1,Type=String,Description="ESP6500 allele frequency (European American population).">
##INFO=<ID=ESP6500AA_AF,Number=1,Type=String,Description="ESP6500 allele frequency (African American population).">
##INFO=<ID=1000G_AF,Number=.,Type=String,Description="1000G global allele frequency (All populations).">
##INFO=<ID=EXAC_AF,Number=1,Type=String,Description="ExAC global allele frequency (All populations).">
##INFO=<ID=HGMD_ID,Number=.,Type=String,Description="HGMD identifier(s)">
##INFO=<ID=SOMATIC,Number=0,Type=Flag,Description="If the variant is somatic.">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GL,Number=G,Type=Float,Description="Genotype Likelihood, log10-scaled likelihoods of the data given the called genotype for each possible genotype generated from the reference and alternate alleles given the sample ploidy">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=RO,Number=1,Type=Integer,Description="Reference allele observation count">
##FORMAT=<ID=QR,Number=1,Type=Integer,Description="Sum of quality of the reference observations">
##FORMAT=<ID=AO,Number=A,Type=Integer,Description="Alternate allele observation count">
##FORMAT=<ID=QA,Number=A,Type=Integer,Description="Sum of quality of the alternate observations">
##SnpSiftVersion="SnpSift 4.1b (build 2015-02-13), by Pablo Cingolani"
##SnpSiftCmd="SnpSift annotate -tabix -id /mnt/share/data/dbs/dbSNP/dbsnp_latest.vcf.gz ./NA12878_var.vcf"
##INFO=<ID=OMIM,Number=.,Type=String,Description="Annotation from /mnt/share/data/dbs/OMIM/omim.bed delimited by ':'">
##INFO=<ID=REPEATMASKER,Number=1,Type=String,Description="Annotation from /mnt/share/data/dbs/RepeatMasker/RepeatMasker.bed delimited by ':'">
##SnpEffVersion="4.1b (build 2015-02-13), by Pablo Cingolani"
##SnpEffCmd="SnpEff  -noStats -no-downstream -no-upstream -no-intergenic hg19 "
##INFO=<ID=CSQ,Number=.,Type=String,Description="Functional annotations: 'Allele|Consequence|IMPACT| Gene_Name | Gene_ID | Feature_Type | Feature_ID | Transcript_BioType | Rank | HGVS.c | HGVS.p | cDNA.pos / cDNA.length | CDS.pos / CDS.length | AA.pos / AA.length | Distance | ERRORS / WARNINGS / INFO' ">
##INFO=<ID=LOF,Number=.,Type=String,Description="Predicted loss of function effects for this variant. Format: 'Gene_Name | Gene_ID | Number_of_transcripts_in_gene | Percent_of_transcripts_affected' ">
##INFO=<ID=dbNSFP_Polyphen2_HDIV_pred,Number=.,Type=Character,Description="Field 'Polyphen2_HDIV_pred' from dbNSFP">
##INFO=<ID=dbNSFP_phyloP100way_vertebrate,Number=.,Type=Float,Description="Field 'phyloP100way_vertebrate' from dbNSFP">
##INFO=<ID=dbNSFP_MutationTaster_pred,Number=.,Type=Character,Description="Field 'MutationTaster_pred' from dbNSFP">
##INFO=<ID=dbNSFP_Polyphen2_HVAR_pred,Number=.,Type=Character,Description="Field 'Polyphen2_HVAR_pred' from dbNSFP">
##INFO=<ID=dbNSFP_SIFT_pred,Number=.,Type=Character,Description="Field 'SIFT_pred' from dbNSFP">
##SnpSiftCmd="SnpSift annotate -mem -sorted -noId -name HGMD_ -info ID,CLASS,MUT,GENE,PHEN /mnt/share/data/dbs/HGMD/HGMD_PRO_2014_4_fixed.vcf"
##INFO=<ID=HGMD_MUT, Number=., Type=String, Description="HGMD mutant allele">
##INFO=<ID=HGMD_PHEN, Number=., Type=String, Description="HGMD primary phenotype">
##INFO=<ID=HGMD_CLASS, Number=., Type=String, Description="Mutation Category, https://portal.biobase-international.com/hgmd/pro/global.php#cats ">
##INFO=<ID=HGMD_GENE, Number=., Type=String, Description="Gene symbol">
##SnpSiftCmd="SnpSift annotate -mem -sorted -noId -name ESP6500EA_ -info AF /mnt/share/data/dbs/ESP6500/ESP6500SI_EA.vcf"
##SnpSiftCmd="SnpSift annotate -mem -sorted -noId -name ESP6500AA_ -info AF /mnt/share/data/dbs/ESP6500/ESP6500SI_AA.vcf"
##SnpSiftCmd="SnpSift annotate -tabix -noId -name 1000G_ -info AF /mnt/share/data/dbs/1000G/ALL.wgs.phase3_shapeit2_mvncall_integrated_v5a.20130502.sites.vcf.gz"
##SnpSiftCmd="SnpSift annotate -tabix -noId -name EXAC_ -info AF /mnt/share/data/dbs/ExAC/ExAC.r0.3.sites.vep.vcf.gz"
##SnpSiftCmd="SnpSift annotate -mem -sorted -noId -name CLINVAR_ -info SIG,ACC /mnt/share/data/dbs/ClinVar/clinvar_converted.vcf"
##INFO=<ID=CLINVAR_SIG, Number=., Type=String, Description="ClinVar clinical significance">
##INFO=<ID=CLINVAR_ACC, Number=., Type=String, Description="ClinVar accession">
##SnpSiftCmd="SnpSift annotate -tabix -noId -name COSMIC_ -info ID /mnt/share/data/dbs/COSMIC/cosmic.vcf.gz"
##INFO=<ID=COSMIC_ID, Number=1, Type=String, Description="COSMIC accession">
##FILTER=<ID=off-target,Description="Variant marked as 'off-target'.">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	NA12878
chr1	62713224	rs2941679	C	G	1166.14	off-target	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=37;CIGAR=1X;DP=37;DPB=37;DPRA=0;EPP=4.47751;EPPR=0;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=55.8981;PAIRED=1;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=1438;QR=0;RO=0;RPL=37;RPP=83.3548;RPPR=0;RPR=0;RUN=1;SAF=16;SAP=4.47751;SAR=21;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=G|missense_variant|MODERATE|KANK4|KANK4|transcript|NM_181712.4|Coding|9/10|c.2803G>C|p.Val935Leu|3180/5477|2803/2988|935/995||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=0.698000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;ESP6500EA_AF=0.9598;ESP6500AA_AF=0.9923;1000G_AF=0.986222;EXAC_AF=0.974	GT:GL:DP:RO:QR:AO:QA	1/1:-129.809,-11.1381,0:37:0:0:37:1438
chr1	62728784	rs2666472	A	G	38124.1	off-target	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=1194;CIGAR=1X;DP=1194;DPB=1194;DPRA=0;EPP=4.8726;EPPR=0;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=1659.84;PAIRED=0.999162;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=44865;QR=0;RO=0;RPL=90;RPP=1872.94;RPPR=0;RPR=1104;RUN=1;SAF=613;SAP=4.8726;SAR=581;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=G|missense_variant|MODERATE|KANK4|KANK4|transcript|NM_181712.4|Coding|7/10|c.2519T>C|p.Val840Ala|2896/5477|2519/2988|840/995||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=2.839000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;ESP6500EA_AF=0.7338;ESP6500AA_AF=0.5581;1000G_AF=0.715855;EXAC_AF=0.740;COSMIC_ID=COSM4144131	GT:GL:DP:RO:QR:AO:QA	1/1:-4038.23,-359.43,0:1194:0:0:1194:44865
chr1	62728838	rs2258470	T	C	35243.1	off-target	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=1128;CIGAR=1X;DP=1128;DPB=1128;DPRA=0;EPP=3.018;EPPR=0;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=1568.35;PAIRED=1;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=42381;QR=0;RO=0;RPL=1102;RPP=2231.8;RPPR=0;RPR=26;RUN=1;SAF=579;SAP=4.74286;SAR=549;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=C|missense_variant|MODERATE|KANK4|KANK4|transcript|NM_181712.4|Coding|7/10|c.2465A>G|p.His822Arg|2842/5477|2465/2988|822/995||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=3.307000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;ESP6500EA_AF=0.7340;ESP6500AA_AF=0.5588;1000G_AF=0.716254;EXAC_AF=0.741	GT:GL:DP:RO:QR:AO:QA	1/1:-3814.67,-339.562,0:1128:0:0:1128:42381
chr1	62728861	rs2260581	T	C	35547.2	off-target	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=1117;CIGAR=1X;DP=1118;DPB=1118;DPRA=0;EPP=4.64522;EPPR=0;GTI=0;LEN=1;MEANALT=2;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=1553.1;PAIRED=1;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=42745;QR=0;RO=0;RPL=1094;RPP=2232.88;RPPR=0;RPR=23;RUN=1;SAF=578;SAP=5.96716;SAR=539;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=C|synonymous_variant|LOW|KANK4|KANK4|transcript|NM_181712.4|Coding|7/10|c.2442A>G|p.Lys814Lys|2819/5477|2442/2988|814/995||;ESP6500EA_AF=0.7338;ESP6500AA_AF=0.5588;1000G_AF=0.716254;EXAC_AF=0.741	GT:GL:DP:RO:QR:AO:QA	1/1:-3847.08,-336.251,0:1118:0:0:1117:42745
chr1	62728918	rs2262110	G	A	5510.87	off-target	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=180;CIGAR=1X;DP=180;DPB=180;DPRA=0;EPP=8.84915;EPPR=0;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=254.138;PAIRED=1;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=6442;QR=0;RO=0;RPL=26;RPP=200.663;RPPR=0;RPR=154;RUN=1;SAF=115;SAP=33.1696;SAR=65;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=A|synonymous_variant|LOW|KANK4|KANK4|transcript|NM_181712.4|Coding|7/10|c.2385C>T|p.Pro795Pro|2762/5477|2385/2988|795/995||;ESP6500EA_AF=0.7338;ESP6500AA_AF=0.5588;1000G_AF=0.716054;EXAC_AF=0.742	GT:GL:DP:RO:QR:AO:QA	1/1:-580.138,-54.1854,0:180:0:0:180:6442
chr1	62740446	rs2666506	T	C	7265.93	.	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=229;CIGAR=1X2M1X;DP=230;DPB=230;DPRA=0;EPP=7.19204;EPPR=0;GTI=0;LEN=1;MEANALT=2;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=322.067;PAIRED=0.995633;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=8223;QR=0;RO=0;RPL=163;RPP=92.2303;RPPR=0;RPR=66;RUN=1;SAF=110;SAP=3.77838;SAR=119;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=C|synonymous_variant|LOW|KANK4|KANK4|transcript|NM_181712.4|Coding|3/10|c.330A>G|p.Pro110Pro|707/5477|330/2988|110/995||;ESP6500EA_AF=0.6742;ESP6500AA_AF=0.8545;1000G_AF=0.804513;EXAC_AF=0.745	GT:GL:DP:RO:QR:AO:QA	1|1:-740.089,-68.9359,0:230:0:0:229:8223
chr1	62740449	rs2666507	T	C	7265.93	.	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=229;CIGAR=1X2M1X;DP=230;DPB=230;DPRA=0;EPP=7.19204;EPPR=0;GTI=0;LEN=1;MEANALT=2;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=322.067;PAIRED=0.995633;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=8223;QR=0;RO=0;RPL=163;RPP=92.2303;RPPR=0;RPR=66;RUN=1;SAF=110;SAP=3.77838;SAR=119;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=C|synonymous_variant|LOW|KANK4|KANK4|transcript|NM_181712.4|Coding|3/10|c.327A>G|p.Ser109Ser|704/5477|327/2988|109/995||;ESP6500EA_AF=0.6734;ESP6500AA_AF=0.7730;1000G_AF=0.78095;EXAC_AF=0.737	GT:GL:DP:RO:QR:AO:QA	1|1:-740.089,-68.9359,0:230:0:0:229:8223
chr1	120539331	rs2124109	C	T	30961.0	.	AB=0.518558;ABP=8.65198;AC=1;AF=0.5;AN=2;AO=978;CIGAR=1X;DP=1886;DPB=1886;DPRA=0;EPP=3.5787;EPPR=3.9669;GTI=0;LEN=1;MEANALT=1;MQM=49.2444;MQMR=59.9615;NS=1;NUMALT=1;ODDS=6584.97;OMIM=600275_[NOTCH2_(provisional)_Alagille_syndrome_2|Hajdu-Cheney_syndrome];PAIRED=1;PAIREDR=0.998899;PAO=0;PQA=0;PQR=0;PRO=0;QA=37778;QR=34919;RO=908;RPL=978;RPP=2126.71;RPPR=1974.71;RPR=0;RUN=1;SAF=481;SAP=3.5787;SAR=497;SRF=444;SRP=3.9669;SRR=464;TYPE=snp;technology.ILLUMINA=1;CSQ=T|intron_variant|MODIFIER|NOTCH2|NOTCH2|transcript|NM_024408.3|Coding|4/33|c.751+289G>A||||||,T|intron_variant|MODIFIER|NOTCH2|NOTCH2|transcript|NM_001200001.1|Coding|4/21|c.751+289G>A||||||;EXAC_AF=0.440;COSMIC_ID=COSM248829	GT:GL:DP:RO:QR:AO:QA	0/1:-3398.11,0,-3140.79:1886:908:34919:978:37778
chr1	120611960	rs2603926	C	T	9242.25	.	AB=0.210718;ABP=1400.06;AC=1;AF=0.5;AN=2;AO=405;CIGAR=1X;DP=1922;DPB=1922;DPRA=0;EPP=3.01566;EPPR=7.99309;GTI=0;LEN=1;MEANALT=1;MQM=47.2642;MQMR=59.5036;NS=1;NUMALT=1;ODDS=2128.11;OMIM=600275_[NOTCH2_(provisional)_Alagille_syndrome_2|Hajdu-Cheney_syndrome];PAIRED=1;PAIREDR=0.999341;PAO=0;PQA=0;PQR=0;PRO=0;QA=15016;QR=56334;RO=1517;RPL=0;RPP=882.457;RPPR=3271.13;RPR=405;RUN=1;SAF=202;SAP=3.01566;SAR=203;SRF=789;SRP=8.33663;SRR=728;TYPE=snp;technology.ILLUMINA=1;CSQ=T|missense_variant|MODERATE|NOTCH2|NOTCH2|transcript|NM_024408.3|Coding|1/34|c.61G>A|p.Ala21Thr|358/11466|61/7416|21/2471||,T|missense_variant|MODERATE|NOTCH2|NOTCH2|transcript|NM_001200001.1|Coding|1/22|c.61G>A|p.Ala21Thr|358/4311|61/3708|21/1235||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=0.433000;dbNSFP_MutationTaster_pred=N;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;EXAC_AF=0.259;COSMIC_ID=COSM1600651	GT:GL:DP:RO:QR:AO:QA	0/1:-1201.38,0,-4920:1922:1517:56334:405:15016
chr1	120612034	rs201668322	T	G	8088.96	.	AB=0.2001;ABP=1560.74;AC=1;AF=0.5;AN=2;AO=399;CIGAR=1X;DP=1994;DPB=1994;DPRA=0;EPP=3.05928;EPPR=10.2653;GTI=0;LEN=1;MEANALT=1;MQM=47.5589;MQMR=59.1103;NS=1;NUMALT=1;ODDS=1862.55;PAIRED=1;PAIREDR=0.999373;PAO=0;PQA=0;PQR=0;PRO=0;QA=14115;QR=56239;RO=1595;RPL=399;RPP=869.428;RPPR=2644.79;RPR=0;RUN=1;SAF=198;SAP=3.05928;SAR=201;SRF=789;SRP=3.40375;SRR=806;TYPE=snp;technology.ILLUMINA=1;CSQ=G|5_prime_UTR_variant|MODIFIER|NOTCH2|NOTCH2|transcript|NM_024408.3|Coding|1/34|c.-14A>C|||||14|,G|5_prime_UTR_variant|MODIFIER|NOTCH2|NOTCH2|transcript|NM_001200001.1|Coding|1/22|c.-14A>C|||||14|;EXAC_AF=0.124	GT:GL:DP:RO:QR:AO:QA	0/1:-1102.26,0,-4893.42:1994:1595:56239:399:14115
chr2	48030692	rs2020910	T	A	288.148	.	AB=0.647059;ABP=6.20364;AC=1;AF=0.5;AN=2;AO=11;CIGAR=1X;DP=17;DPB=17;DPRA=0;EPP=7.94546;EPPR=8.80089;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=60;NS=1;NUMALT=1;ODDS=31.1722;OMIM=600678_[MSH6_(confirmed)_Colorectal_cancer,hereditary_nonpolyposis,type_5|Endometrial_cancer,familial|Mismatch_repair_cancer_syndrome];PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=422;QR=234;RO=6;RPL=8;RPP=7.94546;RPPR=8.80089;RPR=3;RUN=1;SAF=11;SAP=26.8965;SAR=0;SRF=6;SRP=16.0391;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=A|synonymous_variant|LOW|MSH6|MSH6|transcript|NM_000179.2|Coding|5/10|c.3306T>A|p.Thr1102Thr|3458/4328|3306/4083|1102/1360||,A|synonymous_variant|LOW|MSH6|MSH6|transcript|NM_001281492.1|Coding|3/8|c.2916T>A|p.Thr972Thr|3068/3938|2916/3693|972/1230||,A|synonymous_variant|LOW|MSH6|MSH6|transcript|NM_001281493.1|Coding|4/9|c.2400T>A|p.Thr800Thr|3288/4158|2400/3177|800/1058||,A|synonymous_variant|LOW|MSH6|MSH6|transcript|NM_001281494.1|Coding|5/10|c.2400T>A|p.Thr800Thr|3193/4063|2400/3177|800/1058||;ESP6500EA_AF=0.0016;ESP6500AA_AF=0.0100;1000G_AF=0.0493211;EXAC_AF=0.020;CLINVAR_ACC=RCV000030267.2|RCV000078313.2;CLINVAR_SIG=benign|benign	GT:GL:DP:RO:QR:AO:QA	0/1:-37.3387,0,-20.4251:17:6:234:11:422
chr2	215632255	rs2070094	C	T	3342.11	.	AB=0.550459;ABP=5.42083;AC=1;AF=0.5;AN=2;AO=60;CIGAR=2X;DP=109;DPB=109;DPRA=0;EPP=27.4756;EPPR=3.0103;GTI=0;LEN=1;MEANALT=3;MQM=60;MQMR=60;NS=1;NUMALT=2;ODDS=330.697;OMIM=601593_[BARD1_(confirmed)_Breast_cancer,susceptibility_to];PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=2270;QR=75;RO=2;RPL=26;RPP=5.32654;RPPR=7.35324;RPR=34;RUN=1;SAF=17;SAP=27.4756;SAR=43;SRF=1;SRP=3.0103;SRR=1;TYPE=snp;technology.ILLUMINA=1;CSQ=T|missense_variant|MODERATE|BARD1|BARD1|transcript|NM_000465.3|Coding|6/11|c.1519G>A|p.Val507Met|1661/5506|1519/2334|507/777||,T|missense_variant|MODERATE|BARD1|BARD1|transcript|NM_001282543.1|Coding|5/10|c.1462G>A|p.Val488Met|1604/5449|1462/2277|488/758||,T|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282545.1|Coding|2/6|c.216-14976G>A||||||,T|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282548.1|Coding|1/5|c.159-14976G>A||||||,T|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282549.1|Coding|3/4|c.364+24766G>A||||||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=-5.264000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;HGMD_CLASS=DP;HGMD_GENE=BARD1;HGMD_ID=CM034384;HGMD_MUT=ALT;HGMD_PHEN="Breast_cancer,_association_with";ESP6500EA_AF=0.2758;ESP6500AA_AF=0.2901;1000G_AF=0.366214;EXAC_AF=0.378;CLINVAR_ACC=RCV000128872.1;CLINVAR_SIG=benign;COSMIC_ID=COSM3757930	GT:GL:DP:RO:QR:AO:QA	1|0:-351.219,-162.303,-153.666,-207.457,0,-202.81:109:2:75:60:1724
chr2	215632256	rs2070093	A	G	3342.11	.	AB=0.422018;ABP=8.76769;AC=2;AF=1;AN=2;AO=46;CIGAR=1M1X;DP=109;DPB=109;DPRA=0;EPP=21.8927;EPPR=3.0103;GTI=0;LEN=1;MEANALT=3;MQM=60;MQMR=60;NS=1;NUMALT=2;ODDS=330.697;OMIM=601593_[BARD1_(confirmed)_Breast_cancer,susceptibility_to];PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=1724;QR=75;RO=2;RPL=19;RPP=6.03148;RPPR=7.35324;RPR=27;RUN=1;SAF=14;SAP=18.305;SAR=32;SRF=1;SRP=3.0103;SRR=1;TYPE=snp;technology.ILLUMINA=1;CSQ=G|synonymous_variant|LOW|BARD1|BARD1|transcript|NM_000465.3|Coding|6/11|c.1518T>C|p.His506His|1660/5506|1518/2334|506/777||,G|synonymous_variant|LOW|BARD1|BARD1|transcript|NM_001282543.1|Coding|5/10|c.1461T>C|p.His487His|1603/5449|1461/2277|487/758||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282545.1|Coding|2/6|c.216-14977T>C||||||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282548.1|Coding|1/5|c.159-14977T>C||||||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282549.1|Coding|3/4|c.364+24765T>C||||||;ESP6500EA_AF=0.7806;ESP6500AA_AF=0.5835;1000G_AF=0.770567;EXAC_AF=0.813	GT:GL:DP:RO:QR:AO:QA	1|1:-351.219,-162.303,-153.666,-207.457,0,-202.81:109:2:75:60:2270
chr2	215645464	rs2229571	C	G	1317.71	.	AB=0.531646;ABP=3.69747;AC=1;AF=0.5;AN=2;AO=42;CIGAR=1X;DP=79;DPB=79;DPRA=0;EPP=6.31921;EPPR=10.1116;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=60;NS=1;NUMALT=1;ODDS=271.033;OMIM=601593_[BARD1_(confirmed)_Breast_cancer,susceptibility_to];PAIRED=0.97619;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=1570;QR=1399;RO=37;RPL=11;RPP=23.691;RPPR=3.06899;RPR=31;RUN=1;SAF=16;SAP=8.18047;SAR=26;SRF=12;SRP=12.9286;SRR=25;TYPE=snp;technology.ILLUMINA=1;CSQ=G|missense_variant|MODERATE|BARD1|BARD1|transcript|NM_000465.3|Coding|4/11|c.1134G>C|p.Arg378Ser|1276/5506|1134/2334|378/777||,G|missense_variant|MODERATE|BARD1|BARD1|transcript|NM_001282543.1|Coding|3/10|c.1077G>C|p.Arg359Ser|1219/5449|1077/2277|359/758||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282545.1|Coding|2/6|c.215+16321G>C||||||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282548.1|Coding|1/5|c.159-28185G>C||||||,G|intron_variant|MODIFIER|BARD1|BARD1|transcript|NM_001282549.1|Coding|3/4|c.364+11557G>C||||||;dbNSFP_Polyphen2_HDIV_pred=B,B;dbNSFP_phyloP100way_vertebrate=-0.601000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B,B;dbNSFP_SIFT_pred=T;HGMD_CLASS=DP;HGMD_GENE=BARD1;HGMD_ID=CM076014;HGMD_MUT=ALT;HGMD_PHEN="Breast_cancer,_reduced_risk,_association_with";ESP6500EA_AF=0.6008;ESP6500AA_AF=0.3972;1000G_AF=0.459265;EXAC_AF=0.548;CLINVAR_ACC=RCV000132162.1;CLINVAR_SIG=benign;COSMIC_ID=COSM3757931	GT:GL:DP:RO:QR:AO:QA	0/1:-140.558,0,-125.172:79:37:1399:42:1570
chr2	220422774	rs2278201	A	G	23920.4	.	AB=0;ABP=0;AC=2;AF=1;AN=2;AO=748;CIGAR=1X;DP=748;DPB=748;DPRA=0;EPP=9.15313;EPPR=0;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=0;NS=1;NUMALT=1;ODDS=1041.55;OMIM=610991_[OBSL1_(confirmed)_3-M_syndrome_2];PAIRED=1;PAIREDR=0;PAO=0;PQA=0;PQR=0;PRO=0;QA=28048;QR=0;RO=0;RPL=681;RPP=1097.44;RPPR=0;RPR=67;RUN=1;SAF=394;SAP=7.65516;SAR=354;SRF=0;SRP=0;SRR=0;TYPE=snp;technology.ILLUMINA=1;CSQ=G|synonymous_variant|LOW|OBSL1|OBSL1|transcript|NM_015311.2|Coding|11/21|c.3561T>C|p.Pro1187Pro|3875/6112|3561/5691|1187/1896||,G|synonymous_variant|LOW|OBSL1|OBSL1|transcript|NM_001173431.1|Coding|11/14|c.3561T>C|p.Pro1187Pro|3875/5793|3561/4632|1187/1543||;dbNSFP_phyloP100way_vertebrate=-4.618000;dbNSFP_MutationTaster_pred=P;ESP6500EA_AF=0.4331;ESP6500AA_AF=0.5033;1000G_AF=0.419129;EXAC_AF=0.429;COSMIC_ID=COSM3757974	GT:GL:DP:RO:QR:AO:QA	1/1:-2524.69,-225.17,0:748:0:0:748:28048
chr3	10138069	rs2272125	T	G	11320.0	.	AB=0.468057;ABP=9.80783;AC=1;AF=0.5;AN=2;AO=359;CIGAR=1X;DP=767;DPB=767;DPRA=0;EPP=3.74219;EPPR=3.7767;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=60;NS=1;NUMALT=1;ODDS=2606.53;OMIM=613984_[FANCD2_(provisional)_Fanconi_anemia,complementation_group_D2];PAIRED=1;PAIREDR=0.995098;PAO=0;PQA=0;PQR=0;PRO=0;QA=13720;QR=15601;RO=408;RPL=7;RPP=722.953;RPPR=804.241;RPR=352;RUN=1;SAF=178;SAP=3.06474;SAR=181;SRF=200;SRP=3.35092;SRR=208;TYPE=snp;technology.ILLUMINA=1;CSQ=G|synonymous_variant|LOW|FANCD2|FANCD2|transcript|NM_033084.3|Coding|42/43|c.4098T>G|p.Leu1366Leu|4176/5204|4098/4416|1366/1471||,G|synonymous_variant|LOW|FANCD2|FANCD2|transcript|NM_001018115.1|Coding|42/44|c.4098T>G|p.Leu1366Leu|4176/5102|4098/4356|1366/1451||,G|intron_variant|MODIFIER|FANCD2OS|FANCD2OS|transcript|NM_173472.1|Coding|2/2|c.*43+7813A>C||||||;HGMD_CLASS=DP;HGMD_GENE=FANCD2;HGMD_ID=CM066071;HGMD_MUT=ALT;HGMD_PHEN="Breast_cancer,_increased_risk,_association_with";ESP6500EA_AF=0.1647;ESP6500AA_AF=0.4714;1000G_AF=0.242212;EXAC_AF=0.187;COSMIC_ID=COSM3759566	GT:GL:DP:RO:QR:AO:QA	0/1:-1232.96,0,-1402.25:767:408:15601:359:13720
chr3	142178144	rs2229032	C	T	1272.85	.	AB=0.545455;ABP=4.39215;AC=1;AF=0.5;AN=2;AO=42;CIGAR=1X;DP=77;DPB=77;DPRA=0;EPP=85.7331;EPPR=41.7866;GTI=0;LEN=1;MEANALT=1;MQM=60;MQMR=60;NS=1;NUMALT=1;ODDS=251.827;OMIM=601215_[ATR_(confirmed)_Seckel_syndrome_1|Cutaneous_telangiectasia_and_cancer_syndrome,familial];PAIRED=1;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=1615;QR=1358;RO=35;RPL=15;RPP=10.4553;RPPR=6.05036;RPR=27;RUN=1;SAF=16;SAP=8.18047;SAR=26;SRF=9;SRP=20.9405;SRR=26;TYPE=snp;technology.ILLUMINA=1;CSQ=T|missense_variant|MODERATE|ATR|ATR|transcript|NM_001184.3|Coding|43/47|c.7274G>A|p.Arg2425Gln|7396/8251|7274/7935|2425/2644||;dbNSFP_Polyphen2_HDIV_pred=B;dbNSFP_phyloP100way_vertebrate=0.044000;dbNSFP_MutationTaster_pred=P;dbNSFP_Polyphen2_HVAR_pred=B;dbNSFP_SIFT_pred=T;ESP6500EA_AF=0.1578;ESP6500AA_AF=0.0881;1000G_AF=0.102236;EXAC_AF=0.132;CLINVAR_ACC=RCV000123787.1|RCV000145330.1;CLINVAR_SIG=benign|benign;COSMIC_ID=COSM149485	GT:GL:DP:RO:QR:AO:QA	0/1:-144.555,0,-121.429:77:35:1358:42:1615
chr3	142188337	rs28910273	A	C	11942.8	.	AB=0.563235;ABP=26.6283;AC=1;AF=0.5;AN=2;AO=383;CIGAR=1X;DP=680;DPB=680;DPRA=0;EPP=3.69633;EPPR=4.26279;GTI=0;LEN=1;MEANALT=2;MQM=60;MQMR=60;NS=1;NUMALT=1;ODDS=2123.69;OMIM=601215_[ATR_(confirmed)_Seckel_syndrome_1|Cutaneous_telangiectasia_and_cancer_syndrome,familial];PAIRED=0.997389;PAIREDR=1;PAO=0;PQA=0;PQR=0;PRO=0;QA=14643;QR=11374;RO=293;RPL=381;RPP=817.403;RPPR=639.252;RPR=2;RUN=1;SAF=186;SAP=3.69633;SAR=197;SRF=140;SRP=4.26279;SRR=153;TYPE=snp;technology.ILLUMINA=1;CSQ=C|missense_variant|MODERATE|ATR|ATR|transcript|NM_001184.3|Coding|38/47|c.6394T>G|p.Tyr2132Asp|6516/8251|6394/7935|2132/2644||;dbNSFP_Polyphen2_HDIV_pred=B;dbNSFP_phyloP100way_vertebrate=2.346000;dbNSFP_MutationTaster_pred=N;dbNSFP_Polyphen2_HVAR_pred=B;dbNSFP_SIFT_pred=T;ESP6500EA_AF=0.0069;ESP6500AA_AF=0.0020;1000G_AF=0.00199681;EXAC_AF=3.303e-03;CLINVAR_ACC=RCV000145327.1;CLINVAR_SIG=uncertain_significance	GT:GL:DP:RO:QR:AO:QA	0/1:-1313.75,0,-1019.54:680:293:11374:383:14643
